btk degradation as a novel therapeutic strategy for relapsed cns lymphoma
Published 1 year ago • 383 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
1:14
predicting patient response to btk inhibitors using novel approaches
-
3:21
looking beyond jak inhibitors: novel targeted therapies and strategies for mpn treatment
-
1:16
mechanisms of resistance to the tki asciminib in cml
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
4:16
the novel bioactive peptide qub-2392 shows anti-leukemic effects in leukemia cell lines
-
2:57
lp-168: a novel next-generation btk inhibitor with dual activity in cll
-
2:01
next-generation sequencing to analyse t and b cell immune repertoire | protocol preview
-
16:58
novel treatment approaches targeting pi3k, btk, and ezh2
-
5:51
teik talks - functional materials & biomedical devices laboratory
-
4:11
mixed lymphocyte reaction | transplantation immunology
-
25:45
ribosomal synthesis of diketone-containing peptide backbone via post-translational acyl shift
-
14:56
progress report iv - lilien nagy
-
15:09
progress report iv - renáta árok
-
![upgrade your b cell culture [webinar]](https://i.ytimg.com/vi/FSoPgKVW3Xs/mqdefault.jpg)
32:12
upgrade your b cell culture [webinar]
-
3:23:53
ahli seni beladiri
-
4:05
novel therapeutic approaches in all
-
40:17
optimization of bcg and the development of novel intravescial therapeutics
-
1:01
biotechnology and entrepreneurship research | a proposed novel drug treatment of actinic keratosis
-
13:24
progress report iv - petra papócsi
-
3:15
discussion of a novel bioprocessing dna quantification techniques
-
16:54
progress report iv - elias-leon nolden
-
14:50
progress report iv - dávid laczkó